[2] [3] However, there are recognised risks to be aware of: Nutrient deficiencies if food choices during eating windows are poor Disordered eating patterns , particularly in those with a history of restrictive eating Hypoglycaemia in individuals with diabetes or those taking insulin, sulfonylureas, or SGLT2 inhibitors these medication classes carry specific fasting-related risks and require review by a diabetes team before starting IF Fatigue, headaches, and difficulty concentrating , especially during the initial adaptation period Muscle loss if protein intake is insufficient alongside a significant calorie deficit The evidence base, whilst promising, is still evolving
When considering glutathione supplementation, one of the most frequently asked questions is about the effectiveness of various dosages, particularly 100 mg
Gs-biased GLP-1R agonists, characterized by partial Gs recruitment/activation but disproportionately reduced -arrestin recruitment, have been demonstrated to confer superior maximal body weight reduction in preclinical models when compared to balanced agonists such as exendin-4 and semaglutide [58,59,60,61]
Talk to a DevotedDOc physician today
